RankAlpha logo
Back to Rankings

HBIO

Harvard BioscienceB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
HBIO vs peer average
74/100
HBIO vs. peer average (B vs. C)
Grade spread
A 2 · B 2 · D 1 · F 5
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

A is the first available peer comparator.

Agilent is a broad life-science tools benchmark named in the prior baseline, but it is far larger and should not be treated as a direct valuation peer for HBIO.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerAAgilent
HBIO
Harvard Bioscience
A
Agilent
Grade
B
D
Momentum
94
47
Value
68
62
Sentiment
24
33
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs A

HBIO / A
Grade Position
Above peers
HBIO vs. peer average (B vs. C)
74/100
Momentum
94
HBIO
Value
68
HBIO
Sentiment
24
A

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs HBIO
1
A
A
D
40/100
+2
2
RVTY
RVTY
A
100/100
-1
3
TMO
TMO
B
80/100
Even
4
NRSN
Neurosense Therapeutics Ltd Common
F
20/100
+3
5
NEUP
Neuphoria Therapeutics Inc Common
N/A
-
-
A is the first peer returned for this comparison set.